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Abstract
Introduction:  Ischemic  heart  disease  presents  different  features  in  men  and  women.  We  ana-
lyzed the  relation  between  gender  and  prognosis  in  patients  who  had  suffered  a  high-risk  acute
coronary syndrome  (ACS).
Methods:  This  was  a  prospective  analytical  cohort  study  performed  at  Lozano  Blesa  University
Hospital,  Zaragoza,  Spain,  of  559  patients  diagnosed  with  high-risk  ACS  with  and  without  ST-
segment  elevation  according  to  the  American  College  of  Cardiology/American  Heart  Association
guidelines.  The  sample  was  divided  into  two  groups  by  gender  and  differences  in  epidemio-
logic, laboratory,  electrocardiographic  and  echocardiographic  variables  and  treatment  were
recorded. A  Cox’s  proportional  hazard  model  was  applied  and  6-month  mortality  was  analyzed
as the  main  variable.
Results:  The  median  age  was  65.2±12.7  years,  and  21.8%  were  women.  Baseline  characteristics
in women  were  more  unfavorable,  with  higher  GRACE  scores,  older  age,  higher  prevalence  of
hypertension,  diabetes  and  heart  failure,  lower  ejection  fraction  and  more  renal  dysfunction
at admission.  Women  suffered  more  adverse  cardiovascular  events  (27.9%  vs.  15.8%,  p=0.002).
Sixty-four  patients  died,  18.9%  of  the  women  vs.  9.4%  of  the  men  (p=0.004).  After  multivariate
analysis,  female  gender  did  not  present  an  independent  relation  with  mortality.  Hemoglobin
level, renal  function,  ejection  fraction  and  Killip  class  >1  presented  significant  differences.
Conclusions:  Acute  syndrome  coronary  in  women  has  a  worse  prognosis  than  in  men.  Their
adverse course  is  due  to  their  baseline  characteristics  and  not  to  their  gender.
sa  de  Cardiologia.  Published  by  Elsevier  España,  S.L.U.  All  rights© 2012  Sociedade  Portugue
reserved.
∗ Corresponding author.
E-mail address: bzalbaetayo@gmail.com (B. Zalba-Etayo).
http://dx.doi.org/10.1016/j.repc.2014.07.008
0870-2551/© 2012 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. All rights reserved.
44  J.L.  Cabrerizo-García  et  al.
PALAVRAS  CHAVE
Síndrome  coronária
aguda;
Fator  de  risco;
Idade;
Sexo;
Sobrevivência;
Prognóstico
Influência  do  género  no  prognóstico  das  síndromes  coronárias  agudas
Resumo
Introduc¸ão:  A  doenc¸a  cardíaca  isquémica  apresenta  características  diferentes  em  homens  e
mulheres. Foi  analisada  a  relac¸ão  entre  o  sexo  e  o  prognóstico,  em  pacientes  vítimas  de
síndrome coronária  aguda  (SCA)  de  alto  risco.
Métodos:  Estudo  analítico  prospetivo,  de  coorte,  realizado  no  Hospital  Universitário  Lozano
Blesa, Zaragoza,  Espanha.  A  populac¸ão  em  estudo  é  constituída  por  559  pacientes  com  SCA,
com e  sem  elevac¸ão  do  segmento  ST,  de  acordo  com  a  American  College  of  Cardiology/American
Heart Association.  Esta  populac¸ão  foi  dicotomizada  pelo  sexo  e  realizado  um  estudo  compara-
tivo analisando  variáveis  epidemiológicas,  laboratoriais,  eletrocardiográficas,  ecocardiográficas
e de  procedimento  de  tratamento.  Aplicou-se  o  método  de  Cox  para  cálculo  do  risco  pro-
porcional  e  analisou-se  a  taxa  de  mortalidade  como  variável  principal  nos  seis  meses  após  o
evento.
Resultados:  A  idade  média  foi  de  65,2±12,7  anos.  21,8%  dos  doentes  eram  do  sexo  feminino.
Quando  comparadas  com  o  sexo  masculino,  as  características  da  populac¸ão  feminina  eram  mais
desfavoráveis,  apresentando  um  score  GRACE  mais  elevado,  uma  idade  superior  e  uma  maior
prevalência  de  hipertensão  arterial,  diabetes  mellitus  e  de  insuficiência  cardíaca.  A  frac¸ão  de
ejec¸ão era  inferior  e  apresentavam  grau  maior  de  insuficiência  cardíaca  e  de  disfunc¸ão  renal  na
admissão.  As  mulheres  sofreram  mais  eventos  cardiovasculares  adversos  (27,9%  versus  15,8%,
p=0,002).  Sessenta  e  quatro  pacientes  morreram,  sendo  a  mortalidade  no  grupo  das  mulheres
quando  comparada  com  o  grupo  dos  homens  significativamente  superior  (18,9%  versus  9,4%,  p=
0,004). Na  análise  multivariada,  o  sexo  feminino  não  apresenta  relac¸ão  independente  com  a
mortalidade.  Por  outro  lado  o  valor  sérico  de  hemoglobina,  a  func¸ão  renal,  a  frac¸ão  de  ejec¸ão
e Killip  >1  foram  variáveis  identificadas  como  preditoras  de  mortalidade.
Conclusões:  A  síndrome  coronária  agudo  no  grupo  das  mulheres  tem  pior  prognóstico  em  relac¸ão
ao dos  homens.  A  evoluc¸ão  adversa  deve-se  às  características  iniciais  e  não  ao  facto  de  ser  do
sexo feminino.
©  2012  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  España,  S.L.U.  Todos  os
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ardiovascular  disease  (CVD)  is  the  most  common  cause  of
eath  in  women  in  developed  countries  and  is  responsible
or  more  than  the  combined  number  of  deaths  due  to
he  next  seven  causes  and  more  than  all  types  of  cancers
ombined.  In  the  United  States,  CVD  mortality  in  women
xceeds  that  of  men.  Coronary  heart  disease  is  mainly
esponsible  with  24%,1--4 and  although  death  from  ischemic
eart  disease  (IHD)  has  declined  in  men,  its  incidence  is
table  in  women.5,6
Despite  the  burden  of  coronary  disease  in  women,  CVD  is
till  considered  a  disease  of  men  and  there  is  a  false  percep-
ion  that  women  are  in  some  way  protected.  IHD  in  women
ppears  to  have  its  own  characteristics,  although  women  are
elatively  under-represented  in  studies  and  registries.1,7
This  lack  of  representation  in  randomized  clinical  tri-
ls  has  delayed  recognition  of  specific  cardiovascular  risk
actors  by  extrapolating  results  from  studies  of  the  male
opulation.  There  are  significant  gaps  in  knowledge  of  CVD
n  women.  In  an  analysis  of  gender-specific  differences  in
he  characteristics,  development,  management,  and  prog-
osis  of  acute  coronary  syndrome  (ACS)  between  1994  and
002  in  the  RISCI,  PRIAMHO  I  and  II,  Descartes  and  TRI-
NA  trials  conducted  by  the  Working  Group  on  Ischemic
eart  Disease  and  Coronary  Care  Units  of  the  Spanish
ociety  of  Cardiology,  only  24.3%  of  48  369  patients  were
omen.8
W
pOn  average,  women  suffer  myocardial  infarction  (MI)
--10  years  later  than  men,  and  show  a  poorer  prognosis  and
0%  higher  short-term  mortality  than  men,  independently  of
ge.9
The  precise  reasons  for  this  gender  difference  in  the
rognosis  of  acute  IHD  are  unknown.  However,  epidemio-
ogical  studies  suggest  that  differences  in  mortality  cannot
e  explained  by  possible  protective  effects  of  hormones.
hey  give  more  weight  to  elements  of  the  metabolic  syn-
rome,  such  as  hyperlipidemia  or  diabetes,  which  appear
o  be  more  prevalent  in  women,  and  to  differences  in  clin-
cal  presentation  or  disparities  in  the  use  of  diagnostic  and
herapeutic  resources.  Furthermore,  gender-linked  genetic
actors,  which  may  be  critical  to  the  development  of  the
isease,  are  even  less  well  understood.10
It  is  important  to  promote  education  and  discussion  on
he  differences  in  presentation,  development,  and  treat-
ent  of  ACS  in  both  sexes  and  to  obtain  new  indications
or  IHD  in  women.  Editors  of  medical  journals  have  high-
ighted  the  need  for  studies  specifically  on  women  that
ill  indicate  whether  gender  influences  prognosis,  includ-
ng  complications  and  adverse  effects,  in  female  patients
ho  have  suffered  a high-risk  ACS.11
bjectivee  set  out  to  determine  the  differences  in  epidemiology,
resentation  and  evolution  of  high-risk  ACS  in  men  and
es  
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women,  analyzing  the  possible  effect  of  gender  on  mortal-
ity  in-hospital  and  during  a  6-month  follow-up  period  after
the  acute  coronary  event.  We  also  studied  the  association
between  gender  and  adverse  cardiovascular  events  includ-
ing  post-infarction  angina,  reinfarction,  and  heart  failure  in
the  same  follow-up  period.
Methods
This  was  a  prospective  analytical  cohort  study  of  patients
admitted  consecutively  to  our  hospital  between  January
2006  and  December  2007  with  a  diagnosis  of  high-risk
ACS  with  and  without  ST-segment  elevation  according  to
the  criteria  of  the  ACC/AHA  (American  College  of  Cardiol-
ogy/American  Heart  Association).12,13 Patients  were  treated
according  to  the  ACC/AHA  guidelines.
Exclusion  criteria  were  the  presence  of  solid  organ  or
hematological  malignancy,  fever  or  sepsis  at  the  time  of
the  study,  autoimmune  and  inflammatory  diseases,  stage
5  chronic  renal  failure  according  to  the  2002  National
Kidney  Foundation  guidelines,14 and  the  absence  of  reliable
records.  Of  the  590  patients  initially  selected,  31  were
excluded,  and  the  final  sample  analyzed  was  thus  559
patients.
Study  variables
Clinical  variables  analyzed  were  age,  gender,  risk  fac-
tors  (hypertension,  diabetes,  dyslipidemia,  smoking,  heart
failure,  previous  MI),  physical  examination  at  admission
(heart  rate,  systolic  blood  pressure  [BP],  diastolic  BP,  and
pulse  pressure).  Risk  stratification  was  performed  using  the
GRACE  score,  dividing  the  sample  into  three  groups:  low
(≤88  points),  medium  (89--118  points),  and  high  risk  (>118
points).
Laboratory  variables  recorded  within  two  hours  of  admis-
sion  included  hemoglobin,  leukocyte  count,  blood  glucose,
fibrinogen,  uric  acid,  glomerular  filtration  rate  estimated
by  the  4-variable  Modification  of  Diet  in  Renal  Disease
equation,14 creatine  kinase  (CK)  and/or  creatine  kinase-MB
fraction  (CK-MB)  and  troponin  I.  The  biochemical  variables
were  obtained  using  the  Synchron  LX20  Pro  analyzer.
Patients  were  classified  on  the  basis  of  ST-segment  char-
acteristics  on  the  electrocardiogram  into  three  groups:
elevated,  normal,  or  depressed.  The  occurrence  of  cardiac
arrhythmias  during  hospitalization  was  documented.
Left  ventricular  ejection  fraction  (EF)  was  determined  by
echocardiography  at  admission  and  was  classified  as  normal
if  >50%  or  reduced  if  ≤50%.  Patients  with  Killip  class  >1  at
admission  were  considered  to  have  acute  heart  failure.
Reperfusion  therapy  for  patients  with  ST-segment  ele-
vation  ACS  was  divided  into  fibrinolysis  and  percutaneous
coronary  intervention.
The  endpoints  recorded  were  all-cause  mortality  (in-
hospital  or  within  six  months)  and  adverse  cardiovascular
events  (post-infarction  angina,  re-infarction,  and  heart  fail-
ure).  Data  were  collected  by  clinical  and/or  telephone
contact  with  patients  or  their  families.
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tatistical  analysis
ontinuous  variables  were  expressed  as  mean  ±  standard
eviation  and  qualitative  variables  as  frequency  and
ercentage.  Differences  in  quantitative  variables  between
roups  with  a  normal  distribution  were  compared  with  the
tudent’s  t  test  for  independent  samples;  in  cases  of  non-
ormal  distribution,  a  nonparametric  Mann-Whitney  test
as  used.  Discrete  variables  were  compared  using  the  chi-
quare  test  or  Fisher’s  exact  test.  The  independent  variable
f  the  study  was  categorized  according  to  gender.  Cumu-
ative  survival  for  each  category  of  the  main  variable  was
odeled  using  Kaplan-Meier  curves,  and  these  categories
ere  compared  with  the  log-rank  statistic.  To  determine  the
ndependent  role  of  the  variables  in  predicting  mortality,  a
ox  proportional  hazards  analysis  was  performed.  The  esti-
ated  coefficients  were  expressed  as  hazard  ratio  (HR)  with
5%  confidence  intervals  (95%  CI).  The  final  determination  of
ndependent  predictors  of  6-month  mortality  was  performed
n  multivariate  analysis  including  variables  with  p<0.05  in
he  univariate  analysis.  Values  were  considered  significant
t  p<0.05.  The  statistics  software  used  was  SPSS  15.0.
esults
ample  characteristics
he  baseline  characteristics  of  the  559  patients  with  ACS
nrolled  in  the  study  are  shown  in  Table  1.  The  mean
ge  was  65.2±12.7  years  (33--93  years),  and  21.8%  were
omen.  Females  had  lower  diastolic  BP  and  increased  leuko-
yte  count  on  admission,  lower  prevalence  of  dyslipidemia,
ncreased  frequency  of  normal  or  depressed  ST  segment  on
he  electrocardiogram,  and  a  greater  tendency  to  arrhyth-
ias.  Female  gender  was  also  associated  with  older  mean
ge,  higher  heart  rate  and  pulse  pressure  on  admission,
ncreased  prevalence  of  hypertension  and  diabetes  but
ower  prevalence  of  smoking,  more  frequent  history  of  heart
ailure  but  a  lower  incidence  of  previous  stroke,  lower
F,  increased  risk  according  to  the  GRACE  score,  and  a
igher  frequency  of  heart  failure  (Killip  >1)  during  hospi-
alization.  Laboratory  parameters  at  admission  significantly
ssociated  with  female  gender  were  lower  hemoglobin  and
ric  acid  levels  and  worse  renal  function,  and  higher  blood
lucose  and  fibrinogen  concentrations.  Women  more  often
nderwent  primary  angioplasty.  Women  clearly  had  a  worse
rognosis,  with  a  higher  rate  of  adverse  cardiac  events
nd  higher  mortality,  both  in-hospital  and  during  follow-up
Table  2).
ender  as  a  prognostic  factor
here  were  64  deaths  (11.4%),  44  in-hospital,  the  most
requent  causes  for  which  were  cardiogenic  shock  (61.4%),
eart  failure  (13.6%),  and  ventricular  fibrillation  (9.1%).  The
ariables  associated  with  mortality  are  shown  in  Table  3.
n  the  deceased  group  35.9%  were  women  vs.  20%  of  the
o-death  group  (p=0.004).  Other  predictors  of  mortality
ere  age,  hemodynamic  measures  at  admission  (decreased
eart  rate,  systolic  BP,  diastolic  BP,  and  pulse),  laboratory
ests  at  admission  (lower  hemoglobin  concentration  and
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Table  1  Demographic  and  clinical  characteristics  of  the  study  population  at  admission  by  gender.
Men  (n=437)  Women  (n=122)  p
Age  (years) 63.1±12.5 72.7±10.6 <0.001
Examination  at  admission
Heart  rate  (bpm)  76.1±20.1  81.7±22  0.009
Systolic BP  (mmHg)  135±27.1  135.1±30  0.961
Diastolic BP  (mmHg)  79.3±17.5  76.3±18.7  0.105
Pulse pressure  (mmHg)  55.2±18.2  59.2±21.6  0.045
Cardiovascular  risk  factors  (%)
Hypertension  53.3%  63.1%  0.034
Diabetes 19%  32%  0.002
Dyslipidemia  46.5% 43.4% 0.314
Smoking  51% 16.4% <0.001
Cardiac history  (%)
History  of  heart  failure  2.7%  9.8%  0.002
History of  MI  16.9%  8.2%  0.010
Normal or  depressed  ST  segment  35.9%  41.8%  0.140
Depressed EF  (<50%)  33.7%  44.1%  0.034
Low risk  (GRACE  score  ≤88)a 53.4%  29.4%  <0.001
Arrhythmias  22.7%  27.9%  0.141
Laboratory abnormalities  at  admission
Elevated  cardiac  enzymes  (%)b 82.1%  81.8%  0.522
Elevated troponin  I  (%)c 98.2%  99.2%  0.381
Hemoglobin  (g/dl)  14.5±1.8  13±1.7  <0.001
Leukocyte count  (cell/mm3)  11  201.7±3943.9  11  524.8±4840.5  0.449
Blood glucose  (mg/dl)  159.8±82.4  184.7±84.8  0.004
Fibrinogen (mg/dl)  415.6±136.5  454.2±161.6  0.010
Uric acid  (mg/dl)  6.2±1.6  5.7±1.8  0.023
GFR (ml/min/1.73  m2)  80±26  64.5±21.6  <0.001
Killip class  >1  18.5%  36.1%  <0.001
Reperfusion  therapy  in  STEMI
Fibrinolysis  61.8%  52.1%  0.089
PCI 12.2%  28.3%  0.025
BP: blood pressure; EF: ejection fraction; GFR: glomerular filtration rate by the 4-variable Modification of Diet in Renal Disease equation;
MI: myocardial infarction; PCI: percutaneous coronary intervention (with or without stenting); STEMI: ST-segment elevation myocardial
infarction.
a Probability of death at six months after discharge: <3%.
b
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cCK: >300 U/l, CK-MB: CK-MB >25 U/l).
c >0.04 ng/dl.
lomerular  filtration  rate,  increased  blood  glucose,  fib-
inogen  and  leukocyte  count),  history  of  MI  and  absence
f  smoking,  low  EF,  Killip  class  >1,  arrhythmias,  and  not
eing  in  the  low-risk  GRACE  score  group.  The  Kaplan-Meier
h
h
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Table  2  Adverse  cardiovascular  events  and  all-cause  mortality  a
Me
Adverse  cardiovascular  events  at  six  months  (%)  15.
Post-infarction  angina  12%
Reinfarction  4.
Heart failure  4%
Total mortality  at  six  months  (%) 9.
In-hospital mortality  5.
Mortality after  discharge  3.urve  shows  poorer  survival  for  women  (Figure  1).  Women
ad  significantly  higher  mortality  than  men  (18.9  vs.  9.4%,
azard  ratio  [HR]  0.468,  95%  CI:  0.281--0.781,  p=0.004).
n  multivariate  analysis  (adjusted  for  age,  heart  rate,
t  six  months  by  gender.
n  (n=437)  Women  (n=122)  p
8%  27.9%  0.002
 22.8%  0.004
9%  4.4%  0.518
 7.9%  0.075
4%  18.9%  0.004
9%  14.8%  0.002
6%  4.8%  0.378
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Table  3  Individual  variables  associated  with  mortality  at  six  months  after  acute  coronary  syndrome.
Death  (n=64)  No  death  (n=495)  p  HR  (95%  CI)
Female  gender 35.9% 20%  0.004  0.468  (0.28--0.78)
Age (years)  74.9±8.5  63.9±12.6  <0.001  1.091  (1.06--1.12)
Examination  at  admission
Heart  rate  (bpm)  84.3±22.1  76.5±20.2  0.005  1.014(1.00--1.02)
Systolic BP  (mmHg)  121.4±27.1  136.7±27.3  <0.001  0.979  (0.97--0.99)
Diastolic BP  (mmHg)  70.3±15.8  79.7±17.8  <0.001  0.971  (0.96--0.99)
Pulse pressure  (mmHg)  51.3±17.5  56.7±19.1  0.031  0.984  (0.97--1.00)
Smoking 17.2% 46.9% <0.001  0.254  (0.13--0.49)
History of  MI 28.1% 13.3% 0.002 2.322  (1.35--4.00)
Depressed  EF  (<50%) 68.2% 32.7% <0.001 4.088  (2.17--7.71)
Low risk  (GRACE  score  ≤88)a 7.9%  53.4%  0.002  4.979  (1.82--13.6)
Arrhythmias  39.1%  21.8%  0.003  2.139  (1.29--3.53)
Laboratory  abnormalities  at  admission
Hemoglobin  (g/dl)  12.9±2.2  14.3±1.8  <0.001  0.746  (0.67--0.83)
Leucocyte  count  (cell/mm3) 12  412.5±5089  11  124  ±3997.3  0.014  1.000  (1.00--1.00)
Blood glucose  (mg/dl) 194.8±110.9 161.4±78.6  0.002  1.003  (1.00--1.01)
Fibrinogen  (mg/dl)  GFR  (ml/min/1.73  m2) 486.5±202.3 416.3±132.3 <0.001  1.003  (1.00--1.00)
GFR (ml/min/1.73  m2) 56.6±24.6 79.2±24.9  <0.001  0.963  (0.95--0.97)
Killip class  >1  (%) 62.5 17.2 <0.001  6.616  (3.99--10.98)
BP: blood pressure; CI: confidence interval; EF: ejection fraction; GFR: glomerular filtration rate by the 4-variable Modification of Diet
tion.
m
9in Renal Disease equation; HR: hazard ratio; MI: myocardial infarc
a Probability of death at six months after discharge: <3%.
systolic  BP,  diastolic  BP,  and  pulse  pressure  at  admission;
history  of  smoking  and  previous  infarction,  EF,  presence
of  arrhythmias,  severity  on  GRACE  score,  hemoglobin,
leukocytes,  blood  glucose,  fibrinogen,  and  GFR  at  admis-
sion;  and  Killip  class  >1),  gender  as  a  variable  was  not  a
significant  predictor  of  mortality.  Independent  predictors  of
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oortality  were  hemoglobin  level  at  admission  (HR:  0.085;
5%  CI:  0.725--0.996,  p=0.044),  renal  function  at  admission
HR:  0.983,  95%  CI:  0.968--0.999,  p=0.037),  depressed
F  (HR:  2.074,  95%  CI:  1.030--4.176;  p=0.041),  and  heart
ailure  during  hospitalization  as  measured  by  Killip  class  >1
HR:  3.487,  95%  CI:  1.526--7.969,  p=0.003),  the  latter  being
he  main  predictor  factor  of  mortality  (Table  4).
iscussion
he  study  collected  data  prospectively  on  a  consecutive
eries  of  patients  who  suffered  high-risk  ACS  treated  with
n  up-to-date  therapeutic  protocol  for  unstable  IHD.  The
omen  in  the  study  population  were  older  and  had  a  more
nfavorable  clinical  profile,  with  poorer  initial  prognosis
ccording  to  the  GRACE  risk  score,  and  suffered  a  greater
umber  of  adverse  cardiovascular  events  including  post-
nfarction  angina,  reinfarction  and  heart  failure,  as  well  as
ncreased  in-hospital  and  all-cause  mortality,  in  comparison
o  men.  However,  on  multivariate  analysis,  these  gender
ifferences  disappeared,  which  suggests  that  more  or  less
avorable  evolution  depends  to  a  large  extent  on  the  base-
ine  characteristics  of  the  groups.
Women  had  older  mean  age  than  men  (63.1  vs.
2.7  years)  and  began  to  suffer  coronary  acute  events
 decade  later,  which  is  attributable,  in  part,  to  the
rotective  effect  of  estrogens,  according  to  some  studies.15
levated  total  cholesterol,  LDL  cholesterol,  and  triglyceride
evels,  and  lower  HDL-C  levels  during  menopause  may
ontribute  to  the  increased  risk,  especially  from  the  sixth
ecade  of  life.16 In  addition,  estrogens,  through  the  nitric
xide  pathway,  induce  smooth  muscle  cell  dilation  and
48  J.L.  Cabrerizo-García  et  al.
Table  4  Factors  predicting  all-cause  mortality  at  six  months  after  acute  coronary  syndrome  by  Cox  regression  analysis.
p  HR  95%  CI
Lower  Upper
Hemoglobin  at  admission  (g/dl)  0.044  0.085  0.725  0.996
GFR (ml/min/1.73  m2)  at  admission  0.037  0.983  0.968  0.999
Depressed EF  (<50%)  0.041  2.074  1.030  4.176
Killip class  >1  0.003  3.487  1.526  7.969
CI: confidence interval; EF: ejection fraction; GFR: glomerular filtration rate by the 4-variable Modification of Diet in Renal Disease
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nhibit  vascular  proliferation.17,18 For  years,  these  data
ere  considered  to  suggest  that  exogenously  administered
strogen  could  have  a  cardioprotective  effect.  However,
he  results  of  clinical  trials  on  both  primary  (WHI  and
ISDOM)  and  secondary  prevention  (HERS  and  ESPRIT),  and
n  angiographic  endpoints  (WAS,  WELL-HART  and  WAVE),
dvised  against  the  use  of  hormone  replacement  therapy,
howing  negative  results  and  even  greater  progression  of
therosclerosis  and  increased  adverse  effects  such  as  CVD,
eep  vein  thrombosis,  pulmonary  embolism  and  stroke,
ot  to  mention  the  potential  carcinogenic  effect  on  the
reast,  ovaries,  and  endometrium.19,20 Furthermore,  studies
ocused  on  elderly  patients  with  MI  and  a  difference  in  age
f  less  than  one  year  between  women  and  men  have  shown
hat  hospital  mortality  in  women  is  higher  than  in  men  (40%
nd  25%,  respectively),  which  leads  us  to  conclude  that  the
ge  factor  alone  does  not  explain  a  worse  prognosis.  Also,
f  age  is  associated  with  a  higher  prevalence  of  risk  factors
or  cardiovascular  and  other  disease,  then  this  confers  a
reater  early  mortality  in  women  with  MI.21
Cardiovascular  disease  is  characterized  by  multifactorial
tiology.  The  increased  coronary  risk  is  mainly  related  to
isk  factors  that  increase  with  age.  Aging,  hypertension,
yslipidemia,  diabetes,  smoking,  physical  inactivity,  obesity,
nd  family  history  are  important  and  reinforce  each  other.
n  our  results,  a  history  of  hypertension  and  diabetes  was
ssociated  significantly  with  female  gender.
The  prevalence  of  hypertension  in  the  adult  population
s  28%  and  more  women  are  affected  from  the  fifth  or  sixth
ecades  of  life  (52%  vs.  48%  in  men).22 Its  impact  in  the
orm  of  left  ventricular  hypertrophy  is  associated  with  an
ncreased  risk  of  cardiovascular  events,  conferring  a  worse
rognosis  in  women  than  in  men.16 Diabetes,  especially  type
,  is  more  prevalent  in  women  than  in  men,  particularly  after
5  years  of  age,  and  is  the  single  most  potent  cardiovascular
isk  factor  for  coronary  heart  disease.  Its  impact  appears  to
e  even  higher  than  in  men.23
We  observed  higher  mortality  associated  with  greater
enal  dysfunction  and  this  association  was  significant  on
dmission  in  women.  Renal  failure  is  a  poor  prognostic  fac-
or  in  patients  suffering  from  an  acute  coronary  event;
t  is  estimated  that  one  third  of  these  patients  present
enal  dysfunction  on  admission.24 The  above  factors  proba-
ly  contributed  to  the  increased  renal  dysfunction  in  women
n  our  study  and  the  fact  that  women  had  more  prior
eart  failure,  higher  Killip  class  on  admission  and  more
pisodes  of  cardiac  decompensation  after  discharge.  We
lso  observed  lower  EF  values  in  women  and  an  increased
d
>
i
Grequency  of  arrhythmias  during  hospitalization.  Although
omen  had  fewer  previous  episodes  of  IHD  than  males,  their
rognosis  was  less  favorable,  as  also  seen  in  the  BADAPIC
egistry.25
With  regard  to  laboratory  tests  on  admission,  anemia,
yperglycemia,  and  elevated  fibrinogen  levels  were  asso-
iated  with  increased  mortality  in  women;  in  the  case  of
nemia,  even  after  multivariate  analysis.  The  inflammatory
echanism  underlying  vascular  stress  in  acute  coronary
vents  appears  to  contribute  to  these  laboratory  abnormal-
ties.  Elevated  inflammatory  markers  predict  cardiovascular
isk  and  inflammation  may  act  not  only  by  promoting
therogenesis  but  also  by  destabilizing  vulnerable  plaque.
n  a  study  by  Arant  et  al.,26 anemia,  defined  as  a  hemoglobin
evel  of  less  than  12  g/dl,  was  a predictor  of  cardiovascular
vents  following  an  ACS  during  a  follow-up  of  3.3  years.  In
ddition,  various  studies  have  noted  a  relationship  between
he  occurrence  and  severity  of  hyperglycemia  and  increased
orbidity  and  mortality  in  ACS,  independently  of  previously
iagnosed  diabetes.27
Some  studies  have  found  an  association,  at  least  in  part,
etween  the  poorer  prognosis  in  women  and  gender  bias
bserved  in  the  therapeutic  measures  applied,  especially  in
eperfusion  therapy,  whose  benefit  would  be  even  higher
ecause  women  are  higher-risk  patients.28 The  CRUSADE
tudy  data  demonstrate  that  although  IHD  in  women  contin-
es  to  be  associated  with  older  age,  as  well  as  with  a  higher
revalence  of  diabetes  and  hypertension,  the  therapeutic
pproach  continues  to  be  less  aggressive,  with  fewer  coro-
ary  angiograms  and  heparin  treatments.29 We  did  not  find
hese  differences  in  the  group  of  patients  with  ST-segment
levation  (62.8%  of  the  sample),  and  there  were  no  signifi-
ant  differences  in  fibrinolytic  therapy  and  reperfusion  with
rimary  angioplasty,  even  in  women  who  were  more  likely
o  benefit  from  these  treatments.
onclusions
e  believe  that  all  the  risk  factors  known  to  be  associ-
ted  more  closely  with  female  gender  may  be  responsible
or  their  worse  outcome.  The  significance  of  gender  as
uch  is  diluted  in  multivariate  analysis.  The  importance  of
lassical  variables  as  prognostic  markers,  which  are  indepen-
ently  associated  with  higher  mortality  (EF  <50%,  Killip  class
1,  renal  dysfunction  and  anemia  on  admission)  is  increas-
ng.  Women  have  a  high-risk  stratification  according  to  the
RACE  score,  suffer  more  adverse  cardiovascular  events,
es  
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and  have  higher  mortality,  especially  in  the  short  term.  We
are  aware  that  IHD  in  women  is  a  major  problem  whose
importance  is  greater  than  other  conditions  already  known
to  be  leading  causes  of  mortality  in  women,  such  as  breast
cancer.  However,  we  believe  that  before  considering  female
gender  per  se  an  independent  predictor  of  mortality  and
resigning  ourselves  to  the  existence  of  genetic  differences
that  are  not  yet  well  known,  we  should  first  increase  our
efforts  to  include  women  in  scientific  studies  and  discus-
sion  forums  rather  than  merely  extrapolate  research  findings
focused  mostly  on  men.  We  should  also  promote  the  imple-
mentation  of  prevention  campaigns  because,  although  we
deal  with  the  risk  factors  of  men,  the  prevalence  of  dia-
betes,  hypertension,  dyslipidemia,  obesity,  and  smoking  is
still  increasing  in  women.
Our  work  has  several  limitations:  the  sample  size  is  small
and  therefore  so  is  the  number  of  deaths.  A longer  follow-
up  period  would  have  provided  more  information,  and  it
would  also  have  been  interesting  to  investigate  the  causes
of  mortality  during  follow-up.
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